Renal functional contrast-enhanced magnetic resonance imaging: Evaluation of a new rapid-clearance blood pool agent (P792) in Sprague-Dawley rats

Investigative Radiology

Volumn 40, Issue 5, 2005, Pages 295-305

  Mandry, Damien ^a   Pedersen, Michael ^b   Odille, Freddy ^a   Robert, Philippe ^c   Corot, Claire ^c   Felblinger, Jacques ^a   Grenier, Nicolas ^d   Claudon, Michel ^a  

^a HÔPITAL D ENFANTS   (France)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Laboratoire Guerbet   (France)

^d CNRS   (France)

Author keywords

Contrast agents; Contrast media; Experimental studies; Kidney function; Magnetic resonance (MR)

Indexed keywords

BLOOD POOL AGENT; CHELATING AGENT; GADOMELITOL; GADOTERIC ACID; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG DIFFUSION; GLOMERULUS FILTRATION; KIDNEY BLOOD VESSEL; KIDNEY CLEARANCE; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY PELVIS; LOW DRUG DOSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; SIGNAL TRANSDUCTION;

EID: 17644375809     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000160546.04884.91     Document Type: Article

References (41)

1. Bennett HF, Li D. MR imaging of renal function. Magn Reson Imaging Clin N Am. 1997;5:107-126.
2. Grenier N, Basseau F, Ries M, et al. Functional MRI of the kidney. Abdom Imaging. 2003;28:164-175.
3. Knesplova L, Krestin GP. Magnetic resonance in the assessment of renal function. Eur Radiol. 1998;8:201-211.
4. Michaely HJ, Schoenberg SO, Ittrich C, et al. Renal disease: value of functional magnetic resonance imaging with flow and perfusion measurements. Invest Radiol. 2004;39:698-705.
5. Le Blanche AF, Rossert J, Wassef M, et al. MR-Guided PTA in experimental bilateral rabbit renal artery stenosis and MR angiography follow-up versus histomorphometry. Cardiovasc Intervent Radiol. 2000; 23:368-374.
6. Choyke PL, Frank JA, Girton ME, et al. Dynamic Gd-DTPA-enhanced MR imaging of the kidney: experimental results. Radiology. 1989;170: 713-720.
7. Frank JA, Choyke PL, Austin HA, et al. Functional MR of the kidney. Magn Reson Med. 1991;22:319-323.
8. Lee VS, Rusinek H, Johnson G, et al. MR renography with low-dose gadopentetate dimeglumine: feasibility. Radiology. 2001;221:371-379.
9. Baumann D, Rudin M. Quantitative assessment of rat kidney function by measuring the clearance of the contrast agent Gd(DOTA) using dynamic MRI. Magn Reson Imaging. 2000;18:587-595.
10. Choyke PL, Austin HA, Frank JA, et al. Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate. Kidney Int. 1992;41:1595-1598.
11. Laurent D, Poirier K, Wasvary J, et al. Effect of essential hypertension on kidney function as measured in rat by dynamic MRI. Magn Reson Med. 2002;47:127-134.
12. Rohrschneider WK, Haufe S, Wiesel M, et al. Functional and morphologic evaluation of congenital urinary tract dilatation by using combined static-dynamic MR urography: findings in kidneys with a single collecting system. Radiology. 2002;224:683-694.
13. Gates GF. Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). AJR Am J Roentgenol. 1982; 138:565-570.
14. Dawson P, Peters M. Dynamic contrast bolus computed tomography for the assessment of renal function. Invest Radiol. 1993;28:1039-1042.
15. Blomley MJ, Dawson P. Review article: the quantification of renal function with enhanced computed tomography. Br J Radiol. 1996;69: 989-995.
16. Lerman LO, Rodriguez-Porcel M, Romero JC. The development of x-ray imaging to study renal function. Kidney Int. 1999;55:400-416.
17. Fransen R, Muller HJ, Boer WH, et al. Contrast-enhanced dynamic magnetic resonance imaging of the rat kidney. J Am Soc Nephrol. 1996;7:424-430.
18. Wen JG, Chen Y, Ringgaard S, et al. Evaluation of renal function in normal and hydronephrotic kidneys in rats using gadolinium diethyl-enetetramine- pentaacetic acid enhanced dynamic magnetic resonance imaging. J Urol. 2000;163:1264-1270.
19. Daly PF, Zimmerman JB, Gillen JS, et al. Rapid MR imaging of renal perfusion: a comparative study of GdDTPA, albumin-(GdDTPA), and magnetite. Am J Physiol Imaging. 1989;4:165-174.
20. Port M, Corot C, Rousseaux O, et al. P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results. MAGMA. 2001;12:121-127.
21. Port M, Corot C, Raynal I, et al. Physicochemical and biological evaluation of P792, a rapid-clearance blood-pool agent for magnetic resonance imaging. Invest Radiol. 2001;36:445-454.
22. Dirksen MS, Lamb HJ, Kunz P, et al. Improved MR coronary angiography with use of a new rapid clearance blood pool contrast agent in pigs. Radiology. 2003;227:802-808.
23. Taupitz M, Schnorr J, Wagner S, et al. Coronary magnetic resonance angiography: experimental evaluation of the new rapid clearance blood pool contrast medium P792. Magn Reson Med. 2001;46:932-938.
24. Corot C, Violas X, Robert P, et al. Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol. Invest Radiol. 2003;38:311-319.
25. Dewey M, Kaufels N, Laule M, et al. Magnetic resonance imaging of myocardial perfusion and viability using a blood pool contrast agent. Invest Radiol. 2004;39:498-505.
26. Pradel C, Siauve N, Bruneteau G, et al. Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast media. Magn Reson Imaging. 2003;21:845-851.
27. Robert P, Santus R, Violas X, et al. Comparison of the tumoral biodistribution of P792, a rapid clearance blood pool agent and Gd-DOTA in a C6 glioma cerebral tumor model in rats. Acad Radiol 2002;9(suppl2):S521-524.
28. Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official J European Union. 1986;L358:0021-0028.
29. Bourasset F, Dencausse A, Bourrinet P, et al. Comparison of plasma and peritoneal concentrations of various categories of MRI blood pool agents in a murine experimental pharmacokinetic model. MAGMA. 2001;12: 82-87.
30. Rohrschneider WK, Hoffend J, Becker K, et al. Combined static-dynamic MR urography for the simultaneous evaluation of morphology and function in urinary tract obstruction, I. evaluation of the normal status in an animal model. Pediatr Radiol. 2000;30:511-522.
31. Yang D, Ye Q, Williams M, et al. USPIO-enhanced dynamic MRI: evaluation of normal and transplanted rat kidneys. Magn Reson Med. 2001;46:1152-1163.
32. Coulam CH, Lee JH, Wedding KL, et al. Noninvasive measurement of extraction fraction and single-kidney glomerular filtration rate with MR imaging in swine with surgically created renal arterial stenoses. Radiology. 2002;223:76-82.
33. Thurnher S, Tzika AA, Hricak H, et al. Noncontrast and contrast enhanced MR imaging in the evaluation of partial ureteral obstruction: an experimental study in the micropig. Invest Radiol. 1989;24:544-554.
34. Szolar DH, Preidler K, Ebner F, et al. Functional magnetic resonance imaging of human renal allografts during the post-transplant period: preliminary observations. Magn Reson Imaging. 1997;15:727-735.
35. Laissy JP, Menegazzo D, Debray MP, et al. Effect of contrast dilution on contrast-enhanced MR angiography of the aorta and renal arteries. Eur Radiol. 2001;11:1198-1205.
36. de Priester JA, Kessels AG, Giele EL, et al. MR renography by semiautomated image analysis: performance in renal transplant recipients. J Magn Reson Imaging. 2001;14:134-140.
37. Takeda M, Katayama Y, Tsutsui T, et al. Does gadolinium-diethylene triamine pentaacetic acid enhanced MRI of kidney represent tissue concentration of contrast media in the kidney? in vivo and in vitro study. Magn Reson Imaging. 1994;12:421-427.
38. Kennan RP, Zhong J, Gore JC. Intravascular susceptibility contrast mechanisms in tissues. Magn Reson Med. 1994;31:9-21.
39. Bosch CS, Ackerman JJ, Tilton RG, et al. In vivo NMR imaging and spectroscopic investigation of renal pathology in lean and obese rat kidneys. Magn Reson Med. 1993;29:335-344.
40. Prasad PV, Cannillo J, Chavez DR, et al. First-pass renal perfusion imaging using MS-325, an albumin-targeted MRI contrast agent. Invest Radiol. 1999;34:566-571.
41. Fossheim S, Johansson C, Fahlvik AK, et al. Lanthanide-based susceptibility contrast agents: assessment of the magnetic properties. Magn Reson Med. 1996;35:201-206.